Categories: Uncategorized

Dr Reddy’s Laboratories announces commercial launch of anti-COVID 2-DG drug

Dr Reddy’s Laboratories has announced the commercial launch of 2-Deoxy-D-Glucose (2-DG) used to treat Covid patients, adding that the drug will be available across hospitals in metros and Tier 1 cities in the initial weeks.

The drug, developed by DRDO and Dr Reddy’s Laboratories, has been found to help speed up recovery and reduce oxygen dependence. Dr Reddy’s has launched the drug in the form of sachets.

“Dr Reddy’s will supply to major government as well as private hospitals across India. In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India,” the company said in a statement.

The maximum selling price has been capped at ₹ 990, with a discounted rate offered to government institutions, it said.

“2-DG is an oral drug. It can be administered only upon prescription and under the supervision of a qualified physician to hospitalised moderate to severe COVID-19 patients as an adjunct therapy to the existing standard of care,” the company added.

The drug was approved for emergency use in COVID-19 patients on May 1.

AddThis Website Tools
Medically Speaking Team

Recent Posts

Mounjaro Launched in India: Price & Impact on Diabetes and Obesity

Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…

6 hours ago

Shocking Rabies Case in Greater Noida Challenges Common Misconceptions

A recent case of rabies transmission in Greater Noida has sent shockwaves through the community,…

6 hours ago

Punjab Government to Ban Energy Drinks in Schools and Colleges for Student Health

The Punjab government is set to ban high-caffeine energy drinks in schools, citing severe health…

7 hours ago

Experts Warn of Global Threat from Chronic Wasting Disease

Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…

1 day ago

CDC Reschedules Vaccine Advisory Meeting to April 15-16

The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…

1 day ago

India’s Specialty Chemicals Rebound, Pharma Exports Surge

India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…

1 day ago